Screener
Sutro Biopharma STRO Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Sutro Biopharma’s reported figures.
The source filing: Sutro Biopharma’s 10-Q, filed May 14, 2026. Open the filing →
- Filed
- May 14, 2026, 4:30 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-224170
FAQ
- What is Sutro Biopharma's free cash flow?
- Sutro Biopharma (STRO) reported free cash flow of -$42.26M in Q1 2026.
- How has Sutro Biopharma's free cash flow changed year-over-year?
- Sutro Biopharma's free cash flow increased by 37.8% year-over-year, from -$67.91M to -$42.26M.
- What is the long-term trend for Sutro Biopharma's free cash flow?
- Over 2 years (2021 to 2025), Sutro Biopharma's free cash flow has grown at a 47.0% compound annual growth rate (CAGR), from -$82.05M to -$177.24M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Sutro Biopharma's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude